Potential role of eNOS and EDN-1 gene polymorphisms in the development and progression of retinopathy of prematurity
Open Access
- 24 February 2023
- journal article
- research article
- Published by Springer Nature in BMC Ophthalmology
- Vol. 23 (1) , 1-8
Abstract
The aim of this study was to investigate the association between selected polymorphisms of nitric oxide synthetase (eNOS) and endothelin-1 (EDN-1) with the occurrence and progression of retinopathy of prematurity (ROP). A prospective study was conducted on 90 preterm infants (44 female), comparing 39 cases with ROP and 51 controls without ROP. Patients who developed ROP were further divided into two subgroups—those with spontaneous regression of the disease and those with ROP requiring treatment. We found that preterm infants with TT genotype eNOS 894G > T had a 12.8-fold higher risk of developing ROP requiring treatment (p = 0.02). Our results showed that allele T of eNOS894G > T polymorphism was significantly more prevalent in ROP patients requiring treatment (p = 0.029). We also investigated preterm infants with TC genotype eNOS − 786 T > C and found an 8.8-fold higher risk developing of ROP requiring treatment (p = 0.021). Our results didn’t show any association between EDN-1 5665G > T polymorphism and ROP development. The eNOS polymorphisms appears to influence incidence of ROP requiring treatment in preterm infants. Future research on single nucleotide polymorphisms may provide important information about the pathogenetic mechanisms underlying the development of ROP.Keywords
Funding Information
- Research Grant of Doctoral School, Poznan University of Medical Sciences (502-14-11121500-45047)
This publication has 28 references indexed in Scilit:
- The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledgeActa Ophthalmologica, 2013
- Mechanisms and Management of Retinopathy of PrematurityNew England Journal of Medicine, 2012
- Endothelial nitric oxide synthase in the vascular wall: Mechanisms regulating its expression and enzymatic functionArtery Research, 2011
- Endothelin‐1 gene regulationThe FASEB Journal, 2010
- Endothelial Nitric Oxide Synthase genotypes in the etiology of retinopathy of prematurity in premature infantsOphthalmic Genetics, 2010
- Endothelin and NOS1/nitric oxide signaling and regulation of sodium homeostasisCurrent Opinion in Nephrology and Hypertension, 2008
- The International Classification of Retinopathy of Prematurity RevisitedArchives of Ophthalmology (1950), 2005
- Revised Indications for the Treatment of Retinopathy of PrematurityArchives of Ophthalmology (1950), 2003
- Nitric oxideThe International Journal of Biochemistry & Cell Biology, 1997
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988